Table of Contents
1 Table of Contents 3
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of
the Markets/Categories Covered 12
3.1 In Vitro Diagnostics 12
3.1.1
Blood Test Reagents 12
3.1.2 Microbiology Test Reagents 12
4 Company
Snapshot 13
4.1 Key Information 13
4.2 Company Overview 13
4.3
Financial Performance 13
4.4 SWOT Snapshot 13
5 Business Description
14
5.1 Business Overview 14
5.2 Clinical Diagnostics and Blood
Screening products 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3
Market View 14
5.2.4 Key Strategies 15
5.3 Major Products and Services
15
5.3.1 Overview 15
6 History 17
7 Business Strategy 21
7.1
Mission Statement 21
7.2 Strategy 21
7.3 Corporate Social
Responsibility 21
7.3.1 Overview 21
8 Value Chain Analysis 22
8.1
Manufacturing 22
8.1.1 In House Manufacturing 22
8.1.2 Outsourcing
23
8.2 Product Development 23
8.2.1 Regulatory Approvals 23
8.2.2
Clinical Trials 23
8.2.3 Research and Development 23
8.3 Sales and
Marketing 24
8.3.1 Partnerships and Alliances 24
8.3.2 Licensing
Agreements 24
9 SWOT Analysis 25
9.1 Overview 25
9.2 Gen-Probe
Incorporated Strengths 25
9.2.1 Core technologies 25
9.2.2 Constant
financial growth 26
9.2.3 Research and development activities 26
9.3
Gen-Probe Incorporated Weaknesses 26
9.3.1 High focus on North America
26
9.3.2 Product recalls 27
9.3.3 Single third party manufacturers
27
9.4 Gen-Probe Incorporated Opportunities 27
9.4.1 Wide range of FDA
approved products 27
9.4.2 Awards 27
9.5 Gen-Probe Incorporated
Threats 28
9.5.1 Limited manufacturing facilities 28
9.5.2 Use of
biological and harmful materials 28
9.5.3 Implementation problem of
information technology systems 28
10 Competitors 29
11 Gen-Probe
Incorporated Medical Equipment Market Share Analysis 30
11.1 Gen-Probe
Incorporated, Global, Market Share (2007) 30
11.2 Gen-Probe Incorporated,
APAC, Market Share (2007) 31
11.3 Gen-Probe Incorporated, Europe, Market
Share (2007) 32
11.4 Gen-Probe Incorporated, MEA, Market Share (2007)
33
11.5 Gen-Probe Incorporated, North America, Market Share (2007) 34
11.6 Gen-Probe Incorporated, SCA, Market Share (2007) 35
12 Gen-Probe
Incorporated Medical Equipment Market Share Analysis by Category 36
12.1
Gen-Probe Incorporated, In Vitro Diagnostics by Category, Global, Market Share
(2007) 36
12.2 Gen-Probe Incorporated, In Vitro Diagnostics by Category,
APAC, Market Share (2007) 38
12.3 Gen-Probe Incorporated, In Vitro
Diagnostics by Category, Europe, Market Share (2007) 39
12.4 Gen-Probe
Incorporated, In Vitro Diagnostics by Category, MEA, Market Share (2007)
40
12.5 Gen-Probe Incorporated, In Vitro Diagnostics by Category, North
America, Market Share (2007) 41
12.6 Gen-Probe Incorporated, In Vitro
Diagnostics by Category, SCA, Market Share (2007) 42
13 Revenue Analysis
43
13.1 Revenue by Segment 43
13.2 Revenue by Geography 43
14
Financial and Operational Review 44
14.1 Financial Statements 44
14.2
Financial Ratios 45
15 Share Holding Structure 46
16 Key Employees
47
17 Key Employee Biographies 48
18 Company Statement 50
19
Locations And Subsidiaries 55
19.1 Head Office 55
20 Financial Deals
Landscape 56
20.1 Acquisition 56
20.1.1 Gen-Probe Acquires Stake In
Qualigen 56
20.1.2 Gen-Probe to Acquire Innogenetics 57
20.1.3 Xceed
Molecular Enters Into Licensing Agreement with Gen-Probe 59
20.1.4
Millipore Signs an Agreement with Gen-Probe 61
20.1.5 Gen-Probe Signs an
Agreement with 3M Company 62
20.1.6 Gen-Probe Signs an Agreement with 3M
64
20.1.7 Gen-Probe Signs an Agreement with Alnylam Pharmaceuticals 65
20.1.8 Gen-Probe Signs an Agreement with Molecular Profiling Institute 67
20.1.9 Gen-Probe Signs an Agreement with Millipore 68
20.1.10 bioMerieux
Signs An Agreement With Gen-Probe 70
20.1.11 bioMerieux Signs An Agreement
With Gen-Probe 71
21 Recent Developments 73
21.1 Strategy and Business
Planning 73
21.1.1 Jun 17, 2008: 3M Ends Staph-Screening Partnership with
Gen-Probe 73
21.1.2 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop
Rapid Molecular Tests 73
21.2 Financial Announcements 73
21.2.1 Jul
31, 2008: Gen-Probe Declares 2Q 2008 Results 73
21.2.2 Apr 28, 2008:
Gen-Probe Declares Q1 2008 Results 75
21.2.3 Apr 10, 2008: Gen-Probe to
Declare Q1 2008 Results 77
21.2.4 Oct 30, 2007: Gen-Probe Reports Q3 2007
Results 77
21.2.5 Aug 01, 2007: Gen-Probe Declares Q2 2007 Results 79
21.2.6 May 01, 2007: Gen-Probe Declares Q1 2007 Results 81
21.2.7 Feb 13,
2007: Gen-Probe Declares Q4 2006 Results 83
21.2.8 Feb 13, 2007: Gen-Probe
Declares Q4 2007 Results 85
21.3 Other Significant Developments 87
21.3.1 May 19, 2008: Gen-Probe Elects New Board Member 87
21.3.2 Feb 11,
2008: Gen-Probe Appoints President 87
21.3.3 Feb 11, 2008: Gen-Probe
Appoints COO 88
21.3.4 Nov 19, 2007: Gen-Probe Appoints VP, Operations
88
21.3.5 Sep 20, 2007: Gen-Probe Elects New Board Member 88
21.3.6
Feb 13, 2007: Gen-Probe COO To Join 88
22 Gen-Probe Incorporated Pipeline
Products 89
22.1 APTIMA HPV Assay 89
22.1.1 Product Overview 89
22.1.2 Product Description 89
22.1.3 Product Status 89
22.1.4 Clinical
Trials 89
22.1.5 Product Milestone 90
22.2 PROGENSA PCA3 Assay 90
22.2.1 Product Overview 90
22.2.2 Product Description 90
22.2.3
Product Status 91
22.2.4 Clinical Trials 91
22.2.5 Product Milestone
92
22.3 Panther System 92
22.3.1 Product Overview 92
22.3.2
Product Description 92
22.3.3 Product Status 93
22.4
Methicillin-resistant Staphylococcus aureus nucleic acid test 93
22.4.1
Product Overview 93
22.4.2 Product Description 93
22.4.3 Product
Status 93
22.4.4 Product Milestone 94
23 Appendix 95
23.1 Global
Markets Direct Research Methodology 95
23.2 Coverage 96
23.3 Secondary
Research 96
23.4 Primary Research 97
23.5 Models 97
23.6 Forecasts
98
23.7 Expert Panels 98
23.8 Market Revenue Chapters 98
23.8.1
Abbreviations 98
23.8.2 Currency Conversions 99
23.9 About Global
Markets Direct 100
23.10 Contact Us 100
23.11 Disclaimer 100
1.1 List of Tables
Table 1: Gen-Probe Incorporated, Key Facts, 2007
13
Table 2: Gen-Probe Incorporated, SWOT Analysis, 2007 25
Table
3: Gen-Probe Incorporated In Vitro Diagnostics by Geography, Global, Revenue
($ mn) and Market Share (%), 2007 30
Table 4: Gen-Probe Incorporated In
Vitro Diagnostics by Geography, APAC, Revenue ($ mn) and Market Share (%),
2007 31
Table 5: Gen-Probe Incorporated In Vitro Diagnostics by
Geography, Europe, Revenue ($ mn) and Market Share (%), 2007 32
Table 6:
Gen-Probe Incorporated In Vitro Diagnostics by Geography, MEA, Revenue ($ mn)
and Market Share (%), 2007 33
Table 7: Gen-Probe Incorporated In Vitro
Diagnostics by Geography, North America, Revenue ($ mn) and Market Share (%),
2007 34
Table 8: Gen-Probe Incorporated In Vitro Diagnostics by Geography,
SCA, Revenue ($ mn) and Market Share (%), 2007 35
Table 9: Gen-Probe
Incorporated Blood Test Reagents by Geography, Global, Revenue ($ mn) and
Market Share (%), 2007 37
Table 10: Gen-Probe Incorporated Microbiology
Test Reagents by Geography, Global, Revenue ($ mn) and Market Share (%), 2007
37
Table 11: Gen-Probe Incorporated Blood Test Reagents by Geography,
APAC, Revenue ($ mn) and Market Share (%), 2007 38
Table 12: Gen-Probe
Incorporated Blood Test Reagents by Geography, Europe, Revenue ($ mn) and
Market Share (%), 2007 39
Table 13: Gen-Probe Incorporated Microbiology
Test Reagents by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
40
Table 14: Gen-Probe Incorporated Blood Test Reagents by Geography, MEA,
Revenue ($ mn) and Market Share (%), 2007 40
Table 15: Gen-Probe
Incorporated Blood Test Reagents by Geography, North America, Revenue ($ mn)
and Market Share (%), 2007 41
Table 16: Gen-Probe Incorporated Blood Test
Reagents by Geography, SCA, Revenue ($ mn) and Market Share (%), 2007 42
Table 17: Gen-Probe Incorporated, Revenue by Segment, USD Thousand,
2003-2007 43
Table 18: Gen-Probe Incorporated, Revenue by Geography,
USD Thousand, 2003-2007 43
Table 19: Gen-Probe Incorporated,
Financial Statements, USD Thousand, 2003-2007 44
Table 20: Gen-Probe
Incorporated, Financial Ratios, USD Thousand, 2003-2007 45
Table 21:
Gen-Probe Incorporated, Share Holding Structure 46
Table 22:
Gen-Probe Incorporated,Key Employees, 2007 47
Table 23: Abbreviations used
in the Market Revenue Chapters 98
Table 24: Currency Conversion from USD
to Local Currency at 2007 Constant Rate 99
1.2 List of Figures
Figure 1: Gen-Probe Incorporated, Value Chain Analysis 22
Figure 2:
Gen-Probe Incorporated In Vitro Diagnostics, Global, Share of Market (%), 2007
30
Figure 3: Gen-Probe Incorporated In Vitro Diagnostics, APAC, Share of
Market (%), 2007 31
Figure 4: Gen-Probe Incorporated In Vitro Diagnostics,
Europe, Share of Market (%), 2007 32
Figure 5: Gen-Probe Incorporated In
Vitro Diagnostics, North America, Share of Market (%), 2007 34
Figure 6:
Gen-Probe Incorporated In Vitro Diagnostics, SCA, Share of Market (%), 2007
35
Figure 7: Gen-Probe Incorporated In Vitro Diagnostics by Category,
Global, Share of Market (%), 2007 36
Figure 8: Gen-Probe Incorporated In
Vitro Diagnostics by Category, APAC, Share of Market (%), 2007 38
Figure
9: Gen-Probe Incorporated In Vitro Diagnostics by Category, Europe, Share of
Market (%), 2007 39
Figure 10: Gen-Probe Incorporated In Vitro Diagnostics
by Category, North America, Share of Market (%), 2006 41
Figure 11:
Gen-Probe Incorporated In Vitro Diagnostics by Category, SCA, Share of Market
(%), 2006 42
Figure 12: Global Markets Direct Methodology 95
View Cart
